Bembenek, Scott D.

Ligand efficiency and fragment-based drug discovery

Bembenek, S. D., Tounge, B. A., & Reynolds, C. H. (2009) · Drug Discovery Today

Computational Drug Discovery MethodsChemical Synthesis and Analysis

Cited by 196

Pharmacological Characterization of 1-(5-Chloro-6-(trifluoromethoxy)-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic Acid (JNJ-42041935), a Potent and Selective Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor

Barrett, T. D., Palomino, H. L., Brondstetter, T. I., Kanelakis, K. C., Wu, X., Haug, P. V., Yan, W., Young, A., Hua, H., Hart, J. C., et al. (2011) · Molecular Pharmacology

Erythropoietin and Anemia TreatmentCancer, Hypoxia, and Metabolism

Cited by 78